HealthIT startup Preventice brings BodyGuardian monitor to market

sourced

Via News Release

“MINNEAPOLIS, May 10, 2013 — Preventice, Inc., a leading developer of mHealth solutions, announced today the commercial availability of its BodyGuardian Remote Patient Monitoring System (BodyGuardian RMS). Preventice received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in August 2012, enabling the mobile health solutions company to market BodyGuardian for use in detecting and monitoring non-lethal cardiac arrhythmias for ambulatory patients.

Developed in collaboration with Mayo Clinic, the BodyGuardian System uses sophisticated algorithms to support remote monitoring for individuals with cardiac arrhythmias. The BodyGuardian System allows physicians to monitor key biometrics outside of the clinical setting, while patients go about their daily lives.”

Read More…

Comments

Sponsors